14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $12.20 $17.60 Thursday, 2nd May 2024 ENTA stock ended at $13.91. This is 2.58% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 4.19% from a day low at $13.38 to a day high of $13.94.
90 days $11.01 $17.80
52 weeks $8.08 $37.14

Historical Enanta Pharmaceuticals prices

Date Open High Low Close Volume
Mar 29, 2023 $39.49 $40.57 $39.11 $40.27 156 730
Mar 28, 2023 $39.65 $39.97 $38.72 $38.82 90 076
Mar 27, 2023 $40.32 $40.42 $39.71 $39.82 135 825
Mar 24, 2023 $39.29 $41.09 $38.95 $40.07 152 786
Mar 23, 2023 $40.02 $40.45 $38.86 $39.60 172 108
Mar 22, 2023 $40.90 $41.26 $39.54 $39.69 109 302
Mar 21, 2023 $41.98 $43.06 $40.07 $40.89 172 031
Mar 20, 2023 $42.56 $42.78 $41.32 $41.73 251 606
Mar 17, 2023 $42.98 $43.47 $41.85 $42.09 688 581
Mar 16, 2023 $44.15 $44.40 $42.68 $43.42 143 068
Mar 15, 2023 $44.45 $45.00 $43.90 $44.51 239 660
Mar 14, 2023 $46.13 $47.32 $44.28 $45.17 193 320
Mar 13, 2023 $44.73 $46.54 $44.39 $45.07 221 715
Mar 10, 2023 $46.52 $46.52 $43.89 $45.09 171 615
Mar 09, 2023 $47.54 $48.00 $46.35 $46.56 133 095
Mar 08, 2023 $47.35 $47.35 $46.06 $47.17 111 872
Mar 07, 2023 $46.92 $47.86 $46.65 $47.08 162 165
Mar 06, 2023 $47.53 $47.53 $45.76 $46.93 147 888
Mar 03, 2023 $47.69 $48.36 $46.70 $47.51 133 635
Mar 02, 2023 $48.72 $49.27 $47.65 $47.72 175 011
Mar 01, 2023 $48.61 $50.24 $48.61 $49.10 157 013
Feb 28, 2023 $47.95 $49.14 $47.78 $48.50 439 859
Feb 27, 2023 $48.54 $48.75 $47.21 $47.60 125 877
Feb 24, 2023 $48.60 $51.05 $47.74 $47.96 160 067
Feb 23, 2023 $49.77 $49.93 $47.99 $49.04 206 409
Click to get the best stock tips daily for free!

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT